Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomized to DB	STARTED	Oxytocin Nasal Spray	146
Randomized to DB	STARTED	Placebo Nasal Spray	144
Randomized to DB	COMPLETED	Oxytocin Nasal Spray	125
Randomized to DB	COMPLETED	Placebo Nasal Spray	125
Randomized to DB	NOT COMPLETED	Oxytocin Nasal Spray	21
Randomized to DB	NOT COMPLETED	Placebo Nasal Spray	19
Open Label Eligible and Consented	STARTED	Oxytocin Nasal Spray	124
Open Label Eligible and Consented	STARTED	Placebo Nasal Spray	124
Open Label Eligible and Consented	COMPLETED	Oxytocin Nasal Spray	110
Open Label Eligible and Consented	COMPLETED	Placebo Nasal Spray	116
Open Label Eligible and Consented	NOT COMPLETED	Oxytocin Nasal Spray	14
Open Label Eligible and Consented	NOT COMPLETED	Placebo Nasal Spray	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01944046/flow